Intragastric device
An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
1. A drug delivery system comprising:
a volume-occupying subcomponent comprising a self-sealing valve system attached to a wall of a balloon in a central lumen of the balloon by an adhesive with a shear force greater than about 40 N, the self-sealing valve system comprising a septum, a retaining structure, and a continuous ring, wherein the septum has a durometer that is less than a durometer of the retaining structure, wherein the continuous ring is configured to exert a compressive force on the septum, wherein the volume-occupying subcomponent has a weight of less than about 15 g, wherein the volume-occupying subcomponent is configured to have a shape upon full inflation selected from the group consisting of ellipsoid, spheroid, and oblate spheroid, and wherein the volume-occupying subcomponent is configured to have a volume of from about 90 cm 3 to about 350 cm 3 upon full inflation; and
a drug delivery subcomponent.
2. The system of claim 1 , wherein the drug delivery subcomponent further comprises a pharmaceutical substance.
3. The system of claim 2 , wherein the pharmaceutical substance is incorporated into a material forming the volume-occupying subcomponent.
4. The system of claim 2 , wherein the pharmaceutical substance is incorporated into one or more barrier coatings of the volume-occupying subcomponent or a lubricious coating applied to the volume-occupying subcomponent.
5. The system of claim 4 , wherein the one or more barrier coatings comprise a polymer, and wherein release or diffusion properties of the pharmaceutical substance are preselected by modifying characteristics of the polymer or by changing a ratio of hydrophobic to hydrophilic molecules in the composition of the polymer.
6. The system of claim 2 , wherein the drug delivery subcomponent is configured to gradually release the pharmaceutical substance by a pump, a valve, a head breakage, or a disintegration of a head component.
7. The system of claim 2 , wherein the pharmaceutical substance comprises silver ions, and wherein a wall of the volume occupying device comprises a material adapted for ion transfer across it, such that, in vivo, the silver ions diffuse out of the volume-occupying subcomponent or onto its exterior surface, thereby imparting antimicrobial properties to the volume-occupying subcomponent.
8. The system of claim 1 , wherein the drug delivery subcomponent comprises a pharmaceutical substance in at least one degradable pocket formed on an interior surface or an exterior surface of the volume-occupying subcomponent.
9. The system of claim 1 , wherein the drug delivery subcomponent comprises a pharmaceutical substance coated on the outside of the volume-occupying subcomponent.
10. The system of claim 9 , wherein the pharmaceutical substance is incorporated or implanted into a polymer which is sprayed, sputter coated, vapor deposited or applied in liquid form onto an outside of the volume-occupying subcomponent.
11. The system of claim 9 wherein the drug delivery subcomponent comprises a microporous, microsphere, or meshed exterior on the outside of the volume-occupying subcomponent.
12. The system of claim 1 , wherein the drug delivery subcomponent comprises a pharmaceutical substance incorporated into an interior volume of the volume-occupying subcomponent.
13. The system of claim 1 , wherein the drug delivery subcomponent comprises a pharmaceutical substance incorporated into a subcompartment of the volume-occupying subcomponent.
14. The system of claim 13 , wherein the pharmaceutical substance is fixed in a biodegradable plug material configured to release the pharmaceutical substance as the biodegradable plug material degrades in the stomach.
15. The system of claim 1 , wherein an outer layer of the volume-occupying subcomponent possesses antimicrobial properties.
16. The system of claim 1 , wherein the drug delivery subcomponent is one or more reservoirs in the volume-occupying subcomponent adapted to contain a pharmaceutical substance.
17. The system of claim 16 , further comprising a drug polymer or combination of drug polymers positioned in the one or more reservoirs.
18. The system of claim 1 , wherein the drug delivery subcomponent is a plurality of microcapsules on an exterior of the volume-occupying subcomponent, each microcapsule carrying a drug or combination of drugs.
19. The system of claim 1 , wherein the drug delivery subcomponent comprises creases in the volume-occupying subcomponent in its delivery form adapted to contain a pharmaceutical substance, and to release the pharmaceutical substance upon expansion of the volume-occupying subcomponent.
20. The system of claim 1 , wherein the drug delivery subcomponent comprises multiple drugs and is adapted and to release selected drugs upon command.
21. The system of claim 1 , wherein the drug delivery subcomponent comprises drugs layered on top of one another or adjacent to each other on certain portions of the volume-occupying subcomponent.